The CoVAD Study

Listening to the Patient Voice: Empowering physicians to answer meaningful research questions in global rheumatology

[The CoVAD Study @CoVADStudy]

“Pain Levels and Distribution in Idiopathic Inflammatory Myopathies”

Dr. Lekshmi Minikumari Rahulan

Poster View VI
5 June 2026 | 13:30
Poster View Room

[The CoVAD Study @CoVADStudy]

We are pleased to share that abstracts from The CoVAD Study will be presented at the EULAR Congress 2026, at the Excel, London, from 3 to 6 June 2026. If you are attending the congress, we would be delighted to have you with us.

#EULAR #EULAR2026 #CoVAD #Rheumatology

[The CoVAD Study @CoVADStudy]

“Determinants and Phenotypes of Fatigue in Idiopathic Inflammatory Myopathy: A Global Study”

Dr. Meera Shah

Clinical Poster Tours - Novelties in Inflammatory Myopathies
5 June 2026 | 13:30
Poster Tour II

[The CoVAD Study @CoVADStudy]

Are you living with an #autoimmune disease? If you are >18, share your experience in the COVAD-3 survey to help understand your lived experience

Link:https://t.co/aO4DT9el7G

We’d love to reach as many people as possible! @TheMyositisAssc @MyositisSupport @UKMyositis

#myositis

[The CoVAD Study @CoVADStudy]

📣Global COVAD Study: Positions available

2 openings for COVAD4 study- a global collaboration addressing health inequities across diverse populations.

Last date: 15/3/2025

🔗 Apply here:
1. Research Fellow: https://t.co/iAlARqvUWH

2. Study Coordinator: https://t.co/KX1wxDhb8K

[Dr Ai Lyn Tan @DrAiLynTan]

Frequency of minor delayed adverse events, major AEs, & flares following #COVID #vaccination in Autoimmune #Rheumatic Disease in #Malaysia comparable with previous studies

Proud to be part of this truly international collaboration @CoVADStudy @ukm_my
👉🏽https://t.co/pWFpY7Fqqu

[Dr Ai Lyn Tan @DrAiLynTan]

✅Are you healthy?
✅Do you have autoimmune or rheumatic disease?
✅Are you over 18 yrs old?
✅Do you have 15 min?

If you fulfil any of the above, please fill in this anonymous survey to help improve lives of people living with chronic diseases, thanks
👉🏽https://t.co/Bcfezl6Ush

[【公式】一般社団法人日本リウマチ学会 @JcrRyumachi]

【Selected Papers 論文紹介】

『特発性炎症性筋疾患における患者報告アウトカムの性差：COVADデータベースのサブ解析』
吉田　晃

特発性炎症性筋疾患（筋炎）における患者報告アウトカム（Patient-reported outcome measures; PROM）における性差はこれまで十分に検討されていませんでした。2021年に世界中で実施された「自己免疫疾患患者に対する新型コロナワクチン接種に関する研究（COVID-19 Vaccination in Autoimmune Disease; COVAD study）」では、新型コロナウイルスワクチンや疾患活動性に関する情報のみならず、身体機能、痛み、疲労・倦怠感を含む様々なPROMが合わせて収集されました。本研究ではCOVADデータベースより筋炎患者さんのデータを抽出し、PROMの性差を検討しました。
1197名の筋炎患者さんからの回答が解析対象となりました。回答者の70%が女性であり、女性の筋炎患者さんは他の膠原病を2つ以上合併する頻度が高く（女性: 11.4% vs. 男性: 2.8%; P < 0.001）、疲労・倦怠感のVisual analogue scale（VAS）スコアが有意に高値でした（5 [3–7] vs. 4 [2–6] , median [IQR]; P < 0.001）。多変量解析により、女性、高所得国での生活、他の膠原病に伴う筋炎、2つの以上の他の膠原病の合併が、独立して疲労・倦怠感VASスコア高値と関連することが示されました。
本研究の結果から、疾患活動性のみならず患者さんの主観的な体験に注意を払うことの重要性、また他の膠原病を合併する女性の筋炎患者さんが有する疲労・倦怠感への介入の必要性が示唆されました。

https://t.co/5tplF4iMyY

#JCR
#日本リウマチ学会
#ModernRheumatology
#SelectedPapers
#論文紹介

[Abraham E. Gracia R. @Abraham_RMI]

Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international @CoVADStudy
Via @RheumJnl
Congratulations friends 👏🏼🥳🎉
https://t.co/JvrP8FY9d9

[NRAS @NRAS_UK]

The @CoVADStudy team request your help to understand wellbeing of people with autoimmune diseases. Both patients with autoimmune or rheumatic disease and members of your family and friends can take this survey. https://t.co/vko2pSreZf

[Laura Andreoli @lauraandreoli80]

📣Invito alle persone con malattie autoimmuni
📋Per favore dedicate 15 minuti al questionario COVAD-3
📚Aiuterete il gruppo di studio @CoVADStudy a comprendere meglio aspetti ancora poco esplorati come dieta, pianificazione famigliare, etc
In Italiano:
https://t.co/DK1pSCeswO

[Nelly ZIADE 🍀 @Nellziade]

Thank you @eular_org for an amazing congress!

Grateful to present teams' work, chair an incredible 🌍 session, give interviews, learn, report for @ARD_BMJ &amp; meet fantastic people from around the world

Looking forward to Barcelona 2025

@CoVADStudy #EULAR2024
@ArLARheumatolog

[Nelly ZIADE 🍀 @Nellziade]

At the poster tour #EULAR2024

🔴 Proud to present our projects from @CoVADStudy and #ARCH_ArLAR

🔴 Grateful for all who supported our work and presentations

🔴 Excited about future connections and collaborations

@ArLARheumatolog
#teamwork #international

[Ihsane Hmamouchi @epirheum]

😊I'm excited to present our research from @CoVADStudy
at EULAR poster tour tomorrow!

🎤Here's where you can find me:
Location: Hall C. D101
Time: 12:48 PM - 12:54 PM

🌟Discuss findings, answer questions, and let’s connect!

#EULAR24

[Abraham E. Gracia R. @Abraham_RMI]

Scientific abstracts by @CoVADStudy group for #EULAR2024
Via @ARD_BMJ
1. https://t.co/uWh8MTurin
2. https://t.co/HOle8pyFUb
3. https://t.co/kjPuedNyiU
4. https://t.co/Zv3RlH2YiQ
5. https://t.co/9B4zYAwPeB
6. https://t.co/LGc8rDb81Z
7. https://t.co/VzbW3MQaKz
Continue…

[The CoVAD Study @CoVADStudy]

Are you living with an #autoimmune disease? If you are &gt;18, share your experience in the COVAD-3 survey in Spanish to help us understand your lived experience.
Survey Link: https://t.co/74OO1ryvgG
#COVAD3Spanish  #rheumtwitter #MedTwitter

[Abraham E. Gracia R. @Abraham_RMI]

🚨 La encuesta CoVAD-3 ya está está disponible en español!
Todos pueden participar, pero en especial, las personas con enfermedades autoinmunes.
Queremos su opinión sobre distintos aspectos de su condición de vida.
Participa!
Link: https://t.co/Z0OdJojaJy